0001209191-20-047246.txt : 20200818
0001209191-20-047246.hdr.sgml : 20200818
20200818173322
ACCESSION NUMBER: 0001209191-20-047246
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200817
FILED AS OF DATE: 20200818
DATE AS OF CHANGE: 20200818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Dowd Sarah A
CENTRAL INDEX KEY: 0001447149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 201114691
MAIL ADDRESS:
STREET 1: 3185 LAURELVIEW COURT
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-17
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001447149
O'Dowd Sarah A
C/O PROTAGONIST THERAPEUTICS, INC.
7707 GATEWAY BOULEVARD, SUITE 140
NEWARK
CA
94560
1
0
0
0
Stock Option (right to buy)
16.50
2020-08-17
4
A
0
30000
0.00
A
2030-08-16
Common Stock
30000
30000
D
The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of August 12, 2020.
/s/ Donald Kalkofen, Attorney-in-Fact for Sarah A. O'Dowd
2020-08-18